Applications of Viruses for Cancer Therapy, Volume 115

1st Edition

Serial Volume Editors: David Curiel Paul Fisher
Hardcover ISBN: 9780123983428
eBook ISBN: 9780123983695
Imprint: Academic Press
Published Date: 1st October 2012
Page Count: 244
126.00 + applicable tax
101.00 + applicable tax
166.00 + applicable tax
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

Table of Contents

Cover image

Contributors

Chapter One Cancer Terminator Viruses and Approaches for Enhancing Therapeutic Outcomes

1 Introduction

2 Viral Vectors for Cancer Gene Therapy

3 Adenoviruses as Vectors for Cancer Gene Therapy

4 Cancer Terminator Viruses: Efficacious Reagents for Cancer Gene Therapy

5 Approaches Enhancing Therapeutic Outcomes

6 Conclusions and Future Directions

Chapter Two Adenovirus Strategies for Tissue-Specific Targeting

1 Introduction

2 Ad Biology

3 Ad Capsid Structure

4 Ad Entry Biology

5 Transductional Targeting of Ad Vectors

6 Ad Transductional Targeting: Adapter-Based Strategies

7 FAB Antibody Adapters

8 Recombinant Fusion Adapters

9 Alternative Adapter Binding Locales

10 Adapters Utilizing Genetically Modified Ad Capsid

11 Ad Secretion of Adapter

12 Ad Transductional Targeting: Genetically Incorporated Strategies

13 Chimeric Ad

14 Peptide-Targeted Ad

15 “Knob-less”-Targeted Ad

16 Alternative Capsid Locations

17 Novel Transductional Strategies

18 Ad Targeting: Recent Clinical Developments

19 Concluding Remarks

Chapter Three Syrian Hamster as an Animal Model to Study Oncolytic Adenoviruses and to Evaluate the Efficacy of Antiviral Compounds

1 Introduction

2 Existing Animal Models

3 The Syrian Hamster Model

Chapter Four Design of Improved Oncolytic Adenoviruses

1 Introduction

2 Oncolytic Adenovirus Tumor Targeting

3 The Stroma Barrier to Oncolytic Adenovirus Spread

4 Antiadenovirus and Antitumor Immunity in the Outcome of Virotherapy

Chapter Five The Development of Transcription-Regulated Adenoviral Vectors with High Cancer-Selective Imaging Capabilities

1 Introduction

2 Preclinical Molecula


Description

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Applications of viruses for cancer therapy". With outstanding and original reviews, this volume covers topics such as Cancer Terminator Viruses and Approaches for Enhancing Therapeutic Outcomes, esign of improved oncolytic adenoviruses, and Adenovirus-based immunotherapies for cancer.

Key Features

  • Provides invaluable information on the exciting and fast-moving field of cancer research
  • This thematic volume looks at "Applications of viruses for cancer therapy"
  • Outstanding and original reviews

Readership

Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology


Details

No. of pages:
244
Language:
English
Copyright:
© Academic Press 2012
Published:
Imprint:
Academic Press
eBook ISBN:
9780123983695
Hardcover ISBN:
9780123983428

Reviews

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Applications of viruses for cancer therapy". With outstanding and original reviews, this volume covers topics such as Cancer Terminator Viruses and Approaches for Enhancing Therapeutic Outcomes, esign of improved oncolytic adenoviruses, and Adenovirus-based immunotherapies for cancer.


About the Serial Volume Editors

David Curiel Serial Volume Editor

David T. Curiel, M.D., Ph.D. is the Director of the Cancer Biology Division of the Department of Radiation Oncology at Washington University School of Medicine. Dr. Curiel graduated medical school at Emory University in 1982, where he also completed his internship and residency in Internal Medicine. Dr. Curiel’s scientific training includes tenureship at the National Institutes of Health in Bethesda, Maryland at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI) from 1985-1989, and a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch from 1989-1990. He received his Ph.D. from University of Groningen in The Netherlands in 2002. Dr. Curiel has been at Washington University School of Medicine since 2011. In addition to his role as Director of the Cancer Biology Division, he is Director of the Biologic Therapeutics Center.

Affiliations and Expertise

Washington University School of Medicine, St. Louis, MO, USA

Paul Fisher Serial Volume Editor